NCT01375829View on ClinicalTrials.gov

Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 27, 2011

Primary Completion Date

June 26, 2018

Study Completion Date

March 19, 2026

Conditions
Adult Solid Neoplasm
Interventions
DRUG

Ixabepilone

Given IV

OTHER

Pharmacological Study

Correlative studies

DRUG

Temsirolimus

Given IV

Trial Locations (2)

55905

Mayo Clinic in Rochester, Rochester

32224-9980

Mayo Clinic in Florida, Jacksonville

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01375829 - Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter